Pancreatic Cystic Lesions
January 22, 2018
The Continuing Dilemma of Ductal Carcinoma in situ
January 26, 20182017 Symposium
Date: 3/23/2017.
Selected residents / fellows presented brief abstract talks on their recent research. covering any field of pathology, 10-12 minutes with 3-5 minutes for questions.
The presenters:
- Morgan Blakely, MD – Icahn School of Medicine at Mount Sinai: Sentinel Lymph Node Ultrastaging as a Supplement for Endometrial Cancer Intraoperative Frozen Section Deficiencies
- Sarah Glass, MD – New York Presbyterian, Queens: A Pilot Study of PD1 and PD-L1 Expression in a Spectrum of Oral Dysplasia and Oral Squamous Cell Carcinoma
- Gloria Ramos Rivera, MD – Montefiore Medical Center: The ATHENA HPV Study Underrepresents “Other” High Risk HPV Genotypes When Compared to a Diverse New York City Population
- Patrick McIntire, MD – Weill Cornell Medical College: Quality, Not Quantity: 10x Hot-Spot Analysis of Lymphocyte Markers (CD3, CD8, CD4, CD10) in Tumor Infiltrating Lymphocytes is Superior to Whole Tumor Analysis in Triple Negative Breast Cancer
- Deepika Savant, MD – Long Island Jewish Medical Center | Northwell Health: Programmed Cell Death Ligand -1 (PD-L1) Expression in Gastrointestinal Stromal Tumors Correlates Significantly with Presence of Tumor Infiltrating Lymphocytes
- Gunnar Hargu, MD – Columbia University Medical Center: Application of patient-derived induced pluripotent stem cells to analyze neuronal and astrocyte pathology in frontotemporal dementia
- Arash Ronaghy, MD – Lenox Hill Hospital: PD-L1 and Notch1 Expression in KSHV/HHV-8- and -EBV Associated Germinotropic Lymphoproliferative Disorder: a Case Report
- Fang Bu, MD -NYU Langone Medical Center: Altered Methylation of Olfactory Receptor Pathways in Osteosarcoma
- Amir Momeni, MD – SUNY Downstate Medical Center: Mutational Clustering of Endometrial Carcinomas and Their Prognostic Significance: Morphologic Classification is a Better Predictor of Survival Than Mutational Clustering in Endometrial Carcinoma
